AGP Picks
View all

Perspectify logo Perspectify News

Labels

Read articles from across the media landscape with news outlet bias labels for added context. Learn about labels.

Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Hansa Biopharma closes €115m Idefirix licensing deal with SERB

Hansa Biopharma closes €115m Idefirix licensing deal with SERB

European Pharmaceutical Directory 2025 - ResearchAndMarkets.com

European Pharmaceutical Directory 2025 - ResearchAndMarkets.com

Europe moves to strengthen medical oversight after OCCRP exposé on dangerous doctors

Europe moves to strengthen medical oversight after OCCRP exposé on dangerous doctors

Work stress and bad diets raising heart disease risk in UAE's under 50s

Work stress and bad diets raising heart disease risk in UAE's under 50s

To what extent will Trump's tariffs impact Indian pharma? Govt assesses likely cost

To what extent will Trump's tariffs impact Indian pharma? Govt assesses likely cost

Palace Says Viral Photo of Belgium's Future Queen and Prince Georg of Liechtenstein Is Fake By Stephanie Petit

Palace Says Viral Photo of Belgium's Future Queen and Prince Georg of Liechtenstein Is Fake By Stephanie Petit

Referral: Levamisole-containing medicinal products, levamisole, associated names: Decaris,Levamisol Arena Article 31 referrals CMDh final position, 27/03/2026

Referral: Levamisole-containing medicinal products, levamisole, associated names: Decaris,Levamisol Arena Article 31 referrals CMDh final position, 27/03/2026

PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections

PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections

Warning about sharp rise in illegal medicines sold in the EU

Warning about sharp rise in illegal medicines sold in the EU

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema

Dr. Reddy's receives positive CHMP opinion from European Medicines Agency for AVT03 - denosumab

Dr. Reddy's receives positive CHMP opinion from European Medicines Agency for AVT03 - denosumab

Dr Reddy’s biosimilar gets nod from European Medical Agency’s panel

Dr Reddy’s biosimilar gets nod from European Medical Agency’s panel

Is Princess Elisabeth of Belgium dating Prince Georg of Liechtenstein? The potential royal love match explained

Is Princess Elisabeth of Belgium dating Prince Georg of Liechtenstein? The potential royal love match explained

KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year

KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year

UAE to boost number of home-grown doctors with new medicine degree

UAE to boost number of home-grown doctors with new medicine degree

US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028

US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028

ColumnTurning 40 in Phuket: The wellness lessons that now shape my everyday life

ColumnTurning 40 in Phuket: The wellness lessons that now shape my everyday life

'Alarming amounts' of illegal meat and dairy imports could result in a major disease outbreak

'Alarming amounts' of illegal meat and dairy imports could result in a major disease outbreak

EMA warns of sharp rise in illegal medicines sold in EU

EMA warns of sharp rise in illegal medicines sold in EU

EMA's safety committee begins review of levamisole, a medicine used to treat parasitic worm infections

EMA's safety committee begins review of levamisole, a medicine used to treat parasitic worm infections

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.